Riskpilot← Back to searchSign inGet full accessConvilium AB
ABActiveOrg 5590506274Styrbordsvägen 24 BWholesale of pharmaceutical and medical goods · NACE 4646Est. 20161 employees
Revenue 2025
SEK 5,2M
-2% vs 2024
EBITDA margin
16.3%
+438% vs 2024
Equity ratio
56.4%
Financial strength
Net profit 2025
SEK 412K
+10610% vs 2024
| Revenue | SEK 5,2M | -2% |
| EBITDA | SEK 846K | +438% |
| Net profit | SEK 412K | +10610% |
| Total assets | SEK 7,7M | +6% |
| Equity | SEK 4,3M | +10% |
| Employees | 1 | — |
Legal name
Convilium AB
Org number
5590506274
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 februari 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva patologisk distansdiagnostik samt erbjuda läkarbemanning på sjukhus eller universitet som bedriver cancerdiagnostik och därmed förenlig verksamhet.
Address
Styrbordsvägen 24 B
Email
info@convilium.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 4 344 | 4 492 | 14 043 | 6 271 | 6 286 | 6 801 | 5 328 | 5 196 |
| Staff expenses | — | — | — | — | — | — | −496 | — | −183 | −208 |
| EBITDA | 693 | 86 | 819 | 406 | 4 740 | 749 | 552 | 119 | −250 | 846 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −11 | −85 | −85 | −78 | −78 | −78 |
| EBIT | 693 | 86 | 819 | 406 | 4 729 | 664 | 467 | 41 | −329 | 768 |
| Net financials | — | 649 | −1 | — | −2 | −20 | −26 | −67 | −73 | −51 |
| Profit before tax | 694 | 735 | 817 | 406 | 3 547 | 480 | 283 | 34 | 24 | 529 |
| Tax | −153 | −21 | −184 | −92 | −760 | −105 | −65 | −21 | −20 | −117 |
| Net profit | 541 | 714 | 633 | 314 | 2 787 | 375 | 218 | 13 | 4 | 412 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 523 | 1 847 | 1 935 | 2 237 | 7 910 | 7 997 | 7 594 | 7 657 | 7 242 | 7 684 |
| Equity | 591 | 1 142 | 1 612 | 1 642 | 4 253 | 4 268 | 4 296 | 4 119 | 3 923 | 4 334 |
| Long-term debt | 0 | 0 | 0 | 0 | 1 316 | 1 337 | 1 309 | 1 281 | 1 253 | 1 225 |
| Short-term debt | 932 | 705 | 323 | 596 | 1 162 | 1 048 | 540 | 868 | 1 102 | 973 |
| Total debt | 932 | 705 | 323 | 596 | 2 478 | 2 385 | 1 849 | 2 149 | 2 355 | 2 198 |
EBITDA margin
16.3%
This company
15.8%
Market median
+3% vs market
20162025
Equity ratio
56.4%
This company
38.2%
Market median
+48% vs market
20162025
Return on equity
9.5%
This company
18.4%
Market median
-48% vs market
20162025
Net profit margin
7.9%
This company
8.1%
Market median
-2% vs market
20162025
Asset turnover
0.68×
This company
1.12×
Market median
-39% vs market
20162025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-02-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2022 | — | — | |
CM Chief Auditor | Chief Auditor | 2023 | — | — |
HM Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Convilium AB 
Cejo ABBoard members of Convilium AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Charlotte Elisabeth Olsson | Audit | 0 companies |
| Carl Magnus Haak | Chief Auditor | 0 companies |
| Hanna Maria Ryttberg | Audit | 0 companies |
| Eva Cecilia Fråhn Juhlin | Board of Directors | 0 companies |
| Johan Stefan Juhlin | Deputy Board Member | 0 companies |